Amanote Research
Register
Sign In
The WHO 2008 Classification of Ph-Myeloproliferative Disorders: Statement of the Czech MPD Working Group
Leukemia
- United Kingdom
doi 10.1038/leu.2008.93
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
April 17, 2008
Authors
J Schwarz
M Penka
K Indrák
D Pospís̆ilová
R Pytlík
P Dulíc̆ek
M Doubek
L Křen
V Campr
Publisher
Springer Science and Business Media LLC
Related search
The PVSG/WHO Versus the Rotterdam European Clinical, Molecular and Pathological Diagnostic Criteria for the Classification of Myeloproliferative Disorders and Myeloproliferative Neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018
The Revised Who Classification of Myeloproliferative Neoplasms – What Has Changed?
Pathology
Forensic Medicine
Pathology
(Expert Consensus Statement on Prenatal Cardiology Organization in the Czech Republic. Prepared by the Working Group on Pediatric Cardiology of the Czech Society of Cardiology)
Cor et Vasa
Cardiovascular Medicine
Cardiology
The 2008 WHO-classification: Small and Big Changes!
Journal of Hematopathology
Forensic Medicine
Pathology
Hematology
Histology
Impact of the 2016 Revised WHO Criteria for Myeloproliferative Neoplasms, Unclassifiable: Comparison With the 2008 Version
American Journal of Hematology
Hematology
Appendix: Report of the Working Group on Flare Classification
Transactions of the International Astronomical Union
Pathogenesis of Myeloproliferative Disorders
Annual Review of Pathology: Mechanisms of Disease
Medicine
Forensic Medicine
Pathology
Plant Science
Classification of Myeloproliferative Disorders in the JAK2 Era: Is There a Role for Red Cell Mass?
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Role of Vertebral Augmentation in Multiple Myeloma: International Myeloma Working Group Consensus Statement
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
